AAP
AURA icon

Arax Advisory Partners’s Aura Biosciences AURA Stock Holding History

Arax Advisory Partners’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.84K Buy
1,022
+753
+280% +$4.32K ﹤0.01% 2647
2025
Q4 		$1.47K Sell
269
-151
-36% -$897 ﹤0.01% 3375
2025
Q3 		$2.6K Buy
420
+125
+42% +$817 ﹤0.01% 3049
2025
Q2 		$1.85K Buy
+295
New +$1.73K ﹤0.01% 2594
2025
Q1 		– Sell
-102
Closed -$839 – 2692
2024
Q4 		$839 Buy
102
+53
+108% +$499 ﹤0.01% 2208
2024
Q3 		$437 Hold
49
– – ﹤0.01% 2419
2024
Q2 		$371 Buy
+49
New +$359 ﹤0.01% 2372

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $2.28B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return